The Implementation Science Centers in Cancer Control (ISC3) Program is funded by the Cancer MoonshotSM Initiative. The ISC3 program targets the following areas designated as scientific priorities by the Blue Ribbon Panel: Prevention and Screening; Implementation of Evidence-based Approaches; Symptom Management Research; High-Risk Cancers and other cross-cutting Moonshot priorities.
The ISC3 is a unique network as it includes "implementation laboratories" involving clinical and community sites, where Centers' research and methods pilots are conducted.
The 7 funded multidisciplinary and collaborative research Centers form the ISC3 network to advance implementation science by:
- Promoting the development of research centers that can build capacity to study high priority, emerging areas of cancer control implementation science
- Building implementation laboratories in clinical and community settings
- Improving the state of implementation science measurement and methods
- Improving the adoption, implementation, and sustainment of evidence-based cancer control interventions through performing innovative pilot projects to determine best strategies for evidence-based cancer care
- Providing data resources on implementation science; and
- Sharing findings about implementation approaches with the cancer research community
…to reduce the burden of cancer by enhancing the design & delivery of cancer control interventions.
What is the Cancer Moonshot?
The Cancer Moonshot was designed to speed up efforts to prevent, diagnose, and treat cancer. It aims to achieve 10 years of progress in 5 years.
Implementation Science Centers
The ISC3 Program supports P50 Centers under RFA-CA-19-005 and RFA-CA-19-006. NCI has specific responsibilities in providing scientific expertise, coordination, meeting support, and facilitating cross-center collaboration.
NCI ISC3 Staff
